One of the CES presentations I attended was a panel in the sports technology track called, The Future of Fan Engagement. The panel discussed cutting-edge research in the sports tech market and perspectives on the relationship between emergent media technologies and...
Back to team page
Courtney Roberts
Partner
Courtney has 10 years of research experience, ranging from a boutique ethnography firm to a Fortune 500 industrial supply ecommerce company. Courtney brings in-house experience to Bold Insight, having worked closely with designers, developers, product managers, and business stakeholders in both Chicago and Germany. With a focus on quality, speed, and empathy, Courtney conducts and manages both UX and HF projects in the healthcare and consumer space.
Courtney holds an MA in Social Science from the University of Chicago with a focus on sociology and qualitative research methods. You can also find her guest lecturing about design research for a local UX/UI design bootcamp.
Bold facts
Learn more about
Something unique about you summed up in one sentence
Your favorite part of working at Bold Insight
In your spare time (or if you had spare time), you would absolutely do this:
How long have you been in the UX field?
You cannot start the day without doing this…
Your favorite city in the world is...and why?
Your ultimate celebrity dinner party guest list would include:
Long-term personal or professional goal?
- Enhancing medical device safety and effectiveness: Leveraging knowledge tasks in healthcare UX and human factors research
- Bold Insight and Eli Lilly and Company co-publish journal article on novel assessment tool to enhance medical device usability
- Bold Insight to launch AI research project at the 2024 HFES Health Care Symposium
Read our team’s latest bold insights
Just in time for the Super Bowl – A football metaphor for UX research and design
User research and user-centered design are inseparable. We are quarterbacks. We don’t like to run.
The time for a better UX in digital therapeutics is now
If history has shown that payer behavior tends to shift once a critical mass has been achieved, and we are on the precipice of achieving that critical mass for digital therapeutics, having a “user friendly solution” is about to replace “having a reimbursable solution” as the #1 factor affecting physician prescribing behavior.